RORgammaT inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884043
APP PUB NO 20170340610A1
SERIAL NO

15463371

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME LLC126 EAST LINCOLN AVENUE RAHWAY NJ 07065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Azevedo, Rita Corte Real Goncalves 's-Hertogenbosch, NL 3 71
Barr, Kenneth Jay Boston, US 6 99
Beresis, Richard Thomas Shanghai, KR 30 573
Cals, Jos Oss, NL 3 75
Duan, Xiaobang Shanghai, KR 4 75
Karstens, Willem Frederik Johan Berghem, NL 9 92
Van, Der Stelt Mario Utrecht, NL 3 75
Zhang, Dongshan Shanghai, KR 7 144
Zhang, Hongjun Boston, US 73 457

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00